SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001047469-03-005202
Filing Date
2003-02-13
Accepted
2003-02-13 13:34:01
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a2103181zsc13ga.htm SC 13G/A 67125
3 EXHIBIT 99.1 a2103181zex-99_1.htm EX-99.1 8823
  Complete submission text file 0001047469-03-005202.txt   78261
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601
Business Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601 2019680980
DOV PHARMACEUTICAL INC (Subject) CIK: 0001066833 (see all company filings)

IRS No.: 223374365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-78237 | Film No.: 03558222
SIC: 2834 Pharmaceutical Preparations